Vapogenix is a clinical-stage pharmaceutical company based in Houston, TX, dedicated to revolutionizing pain treatment through the development and commercialization of a new class of non-opioid topical analgesics. Their locally acting formulation of volatile general anesthetics offers rapid and prolonged pain relief, reducing or eliminating the need for chronic opioid use and avoiding systemic side effects.
With a focus on addressing the inadequacies of current pain treatment options, Vapogenix aims to provide effective solutions for severe pain from acute injuries and chronic wounds. Their innovative approach not only alleviates pain but also mitigates the risks associated with opioid analgesics, such as addiction and dependence, while reducing the likelihood of developing chronic pain and post-traumatic stress disorder.
Generated from the website